Hikal Ltd
About
Hikal, established in 1988, specialises in the life sciences value chain. It caters to companies in the pharmaceuticals, biotech, crop protection, animal health, and specialty chemicals businesses. In addition to providing active pharmaceutical ingredients (APIs) and intermediates, Hikal also offers contract research and custom synthesis facilities through its manufacturing plants in Gujarat and Karnataka. It uses modern technology like gas chromatography, nuclear magnetic resonance spectrometers, and more for its crop protection vertical. Specialty biocides, antimicrobial actives, and additives for paint coatings, leathers, water treatment, and paper are provided by Hikal’s Specialty Chemicals division. Its manufacturing facilities are located in Taloja and Majad in Maharashtra, Panoli in Gujarat, and Jigani in Karnataka, while the R&D activities are carried out in Pune, Maharashtra.
Featured In Fortune India Ranking
Financial Data 2024
Financial Data
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1768 -13.5% | 2043 3.0% | 1983 15.1% | 1724 13.7% | 1517 -5.6% | 1607 22.0% | 1317 31.3% | 1003 10.1% | 911 3.7% | 878 0.4% | 875 29.0% | 678 -2.7% | 697 30.9% | 532 -2.2% | 544 -1.5% | 552 - |
| Net Operating Income (INR Cr) | 1785 -11.79% | 2023 4.13% | 1943 12.92% | 1720 14.14% | 1507 -5.18% | 1590 22.65% | 1296 27.83% | 1014 9.54% | 926 6.17% | 872 5.14% | 829 25.56% | 660 -6.70% | 708 40.92% | 502 -6.80% | 539 -5.92% | 573 19.48% |
| Profit (INR Cr) | 70 -11.2% | 78 -51.2% | 161 20.6% | 133 57.7% | 84 -18.1% | 103 33.5% | 77 14.0% | 68 64.4% | 41 2.0% | 40 -36.8% | 64 153.1% | 25 -45.1% | 46 24.3% | 37 407.8% | 7 -82.0% | 40 - |
| Assets (INR Cr) | 2093 7.3% | 1950 8.6% | 1796 14.7% | 1566 5.7% | 1481 3.3% | 1433 8.6% | 1320 8.5% | 1217 12.8% | 1079 -1.1% | 1091 2.8% | 1061 1.7% | 1044 7.6% | 970 2.8% | 944 6.8% | 884 -7.7% | 957 - |
| Net Worth (INR Cr) | 1188 4.8% | 1133 6.1% | 1068 14.4% | 933 14.3% | 817 8.0% | 756 13.0% | 669 10.7% | 605 32.0% | 458 7.5% | 426 7.2% | 398 16.1% | 342 6.4% | 322 10.6% | 291 5.8% | 275 8.4% | 254 46.8% |
| Employee Cost (INR Cr) | 247 10.8% | 222 9.4% | 203 23.8% | 164 5.0% | 157 15.4% | 136 6.0% | 128 9.7% | 117 6.4% | 110 20.7% | 91 13.2% | 80 14.4% | 70 10.2% | 64 8.1% | 59 21.4% | 49 -4.3% | 51 - |
| Interest Cost (INR Cr) | 56 | 48 | 31 | 36 | 52 | 58 | 49 | 48 | 62 | 60 | 68 | 60 | 66 | 44 | 38 | 28 |
| Cash & Bank Balance (INR Cr) | 21 | 60 | 49 | 37 | 64 | 32 | 27 | 16 | 19 | 14 | 28 | 15 | 7 | 10 | 13 | 10 |
| Total Debt (INR Cr) | 818 | 748 | 675 | 610 | 646 | 661 | 635 | 598 | 505 | 547 | 546 | 584 | 533 | 536 | 499 | 582 |
Key Financial Ratios
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 3.9% | 3.8% | 8.1% | 7.7% | 5.6% | 6.4% | 5.9% | 6.8% | 4.5% | 4.6% | 7.3% | 3.7% | 6.6% | 7.0% | 1.3% | 7.3% |
| Profit As % Of Assets | 3.3% | 4.0% | 8.9% | 8.5% | 5.7% | 7.2% | 5.9% | 5.6% | 3.8% | 3.7% | 6.0% | 2.4% | 4.7% | 3.9% | 0.8% | 4.2% |
| Profit As % Of Networth | 5.9% | 6.9% | 15.0% | 14.3% | 10.3% | 13.6% | 11.5% | 11.2% | 9.0% | 9.5% | 16.1% | 7.4% | 14.3% | 12.7% | 2.7% | 16.0% |
| Interest Cost to EBITDA % | 21.1% | 18.7% | 9.2% | 11.2% | 20.3% | 19.6% | 20.3% | 24.9% | 34.4% | 32.9% | 36.4% | 44.1% | 42.1% | 41.0% | 32.6% | 31.6% |
| Debt to Equity Ratio | 0.69 | 0.66 | 0.63 | 0.65 | 0.79 | 0.87 | 0.95 | 0.99 | 1.10 | 1.28 | 1.37 | 1.70 | 1.65 | 1.84 | 1.81 | 2.29 |
| RONW | 6.0% | 7.1% | 16.0% | 15.2% | 12.1% | 14.5% | 12.1% | 12.7% | 9.3% | 9.8% | 17.3% | 18.8% | 19.7% | 13.1% | 41.2% | 26.6% |
| ROCE | 7.5% | 8.2% | 14.9% | 15.9% | 13.4% | 15.1% | 12.7% | 11.7% | 11.8% | 12.4% | 17.6% | 15.8% | 16.4% | 9.8% | 17.7% | 12.7% |